Schedule 13D ownership disclosure
Greenwich Lifesciences Inc
Security class unavailable · CUSIP: 396879108
Event date: 2020-09-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 64.9800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-20-019252
- Form type
- SC 13D
- Filer
- Greenwich LifeSciences, Inc.
- CIK
- CIK 1799788
- Filed
- Oct 13, 2020
- Reporting period
- Sep 29, 2020
- Description
- Schedule 13D beneficial ownership